ArticleBMC infectious diseases2026
Hybrid modeling and forecasting of COVID-19: integrating SEAIQHRD and GPR for improved predictions.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study introduces a dual-hybrid COVID-19 forecasting modeling approach that integrates an eight-compartment SEAIQHRD model with Gaussian Process Regression (GPR) and ARIMA-based residual learning to enhance predictive performance. A central methodological contribution is the incorporation of convergence and stability diagnostics, demonstrating reliable parameter estimation through multi-start optimization and bootstrap analysis. Although the SEAIQHRD model captures core disease progression, it is limited in representing nonlinear multi-wave patterns and reporting inconsistencies. The SEAIQHRD–ARIMA hybrid improves short-term linear adjustments, while the SEAIQHRD–GPR hybrid effectively models nonlinear residual structure and provides uncertainty-aware forecasts. Using COVID-19 data from India, both hybrids outperform the standalone model, with the GPR variant yielding the greatest accuracy. Forecast superiority, confirmed by DM, CW, GW, Wilcoxon, and Friedman tests, underscores the robustness and applicability of the proposed modeling approach for public-health.Clinical trial Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.